The influenza virus' ability to mutate quickly has produced new, emerging strains that make drug discovery more critical than ever. For the first time, researchers at Seattle BioMed, along with collaborators at the University of California, San Diego School of Medicine, St. Jude Children's Research Hospital and the University of Washington, have mapped how critical molecules regulate both the induction and resolution of inflammation during flu infection. The results are published this month in the journal Cell...
-
Source: http://www.medicalnewstoday.com/releases/262969.php
--
Manage subscription | Powered by rssforward.com
09 Jul, 2013
-
Source: http://www.medicalnewstoday.com/releases/262969.php
--
Manage subscription | Powered by rssforward.com
Post a Comment